Search

Your search keyword '"Hasford, J."' showing total 351 results

Search Constraints

Start Over You searched for: Author "Hasford, J." Remove constraint Author: "Hasford, J." Search Limiters Full Text Remove constraint Search Limiters: Full Text
351 results on '"Hasford, J."'

Search Results

2. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

5. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

6. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

8. Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

9. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

10. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

11. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

13. Arzneimittelprüfung an nicht einwilligungsfähigen Erwachsenen: Kritische Bewertung der neuen gesetzlichen Regelung durch medizinische Ethikkommissionen in Deutschland [Critical evaluation of the new legal regulation of pharmaceutical trials with adults who lack decision-making capacity: a survey of human research ethics committees in Germany]

17. The German competence network ‘Acute and chronic leukemias’

20. Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea

24. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

30. Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol

32. Abstract

33. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

34. Ethik-Kommissionen im Kontext von 'Klasse statt Masse'. Möglichkeiten, Herausforderungen, neue Wege

35. ASSESSMENT OF IMATINIB 400MG AS FIRST LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: 10-YEAR SURVIVAL RESULTS OF THE RANDOMIZED CML STUDY IV

37. A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction

38. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials

40. The long term outcome of the patients with chronic myeloid leukemia (CML) who have achieved complete cytogenetic response (CCgR) to interferon-alpha (IFN alpha). A collaborative European study of 317 cases

42. Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project

43. Tiotropium Respimat© vs. HandiHaler©: Real-life usage and TIOSPIR trial generalizability

44. Relative Überlebenswahrscheinlichkeiten bei chronischer myeloischer Leukämie im Vergleich mit kumulativen Inzidenzwahrscheinlichkeiten an der Erkrankung zu versterben

45. ANALYSIS OF TREATMENT AND OUTCOME DATA OF 2904 PATIENTS FROM THE EUTOS POPULATION-BASED REGISTRY

46. Seasonal changes in prescribing of longacting beta-2-agonists-containing drugs

47. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

48. A methodological comparison of two European primary care databases and replication in a US claims database : inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction

49. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

50. A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction

Catalog

Books, media, physical & digital resources